Mesenchymal stem cells in kidney inflammation and repair
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2011/12/28
-
Journal
-
Indian UGC (journal)
-
Refrences107
-
Citations72
-
ANDREA F. WISE
-
SHARON D. RICARDO
Abstract
Cite
WISE, ANDREA F., and SHARON D. RICARDO. “Mesenchymal Stem Cells in Kidney Inflammation and Repair”. Nephrology, vol. 17, no. 1, 2011, pp. 1-10, https://doi.org/10.1111/j.1440-1797.2011.01501.x.
WISE, A. F., & RICARDO, S. D. (2011). Mesenchymal stem cells in kidney inflammation and repair. Nephrology, 17(1), 1-10. https://doi.org/10.1111/j.1440-1797.2011.01501.x
WISE, ANDREA F., and SHARON D. RICARDO. “Mesenchymal Stem Cells in Kidney Inflammation and Repair”. Nephrology 17, no. 1 (2011): 1-10. https://doi.org/10.1111/j.1440-1797.2011.01501.x.
WISE AF, RICARDO SD. Mesenchymal stem cells in kidney inflammation and repair. Nephrology. 2011;17(1):1-10.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the genitourinary system
Urology
Medicine
Medicine (General)
You May Also Like
- Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies
- Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country
- What do we know about chronic kidney disease in India: first report of the Indian CKD registry
- Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
- Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury | International Journal of Molecular Medicine |
| 2004 | |
| Acute renal failure in the new millennium: Time to consider combination therapy | Seminars in Nephrology |
| 2000 | |
| Ex‐vivo expansion and subsequent infusion of human bone‐marrow‐derived stromal progenitor cells (mesenchymal progenitor cells) – implications for therapeutic use | Bone Marrow Transplantation |
| 1995 | |
| Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats | 1994 | |||
Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. | The Journal of Experimental Medicine |
| 1,265 | 1992 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Human Wharton's jelly-derived mesenchymal stromal stem cells preconditioned with valproic acid promote cell migration and reduce renal inflammation in ischemia/reperfusion injury by activating the AKT/P13K and SDF1/CXCR4 pathways | Archives of Biochemistry and Biophysics |
| 2024 | |
Electric field-directed migration of mesenchymal stem cells enhances their therapeutic potential on cisplatin-induced acute nephrotoxicity in rats | Naunyn-Schmiedeberg's Archives of Pharmacology |
| 3 | 2023 |
| Simultaneous late-gadolinium enhancement and T1 mapping of fibrosis and a novel cell-based combination therapy in hypertensive mice | Biomedicine & Pharmacotherapy |
| 2 | 2023 |
| Combination therapy with DHA and BMSCs suppressed podocyte injury and attenuated renal fibrosis by modulating the TGF- β 1/Smad pathway in MN mice | Renal Failure |
| 2023 | |
Mesenchymal Stem Cell Therapy in Kidney Diseases: Potential and Challenges | Cell Transplantation |
| 4 | 2023 |
Citations Analysis
The category
Medicine: Medicine (General) 35
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Mesenchymal stem cells and kidney repair and was published in 2012. The most recent citation comes from a 2024 study titled Human Wharton's jelly-derived mesenchymal stromal stem cells preconditioned with valproic acid promote cell migration and reduce renal inflammation in ischemia/reperfusion injury by activating the AKT/P13K and SDF1/CXCR4 pathways. This article reached its peak citation in 2014, with 12 citations. It has been cited in 57 different journals, 29% of which are open access. Among related journals, the PLOS ONE cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.